Startup Observer.com
  • Home
  • Industries
  • Innovation
  • outsourcing
  • Business
  • Finance
  • Headlines
  • Opinion
  • News
Home News Moderna to recall COVID-19 doses in Japan after stainless steel contaminants found
News

Moderna to recall COVID-19 doses in Japan after stainless steel contaminants found

by jcp September 1, 2021
September 1, 2021
gawdo

By Rocky Swift and Carl O’Donnell

TOKYO (Reuters) -Moderna Inc and Takeda Pharmaceutical Co Ltd on Wednesday said they are working with Japanese authorities to recall three batches of COVID-19 vaccine after an investigation found stainless steel contaminants in some vials.

Japanese authorities had suspended use of these batches of Moderna shots containing 1.63 million doses last week after being notified of the contamination issue.

Japan’s health ministry said on Wednesday, based on information from the companies’ investigation, that it did not believe the particles of stainless steel pose any additional health risk. Moderna said the stainless steel contamination probably occurred during production.

Takeda distributes the Moderna vaccine in Japan.

The most probable cause of contamination was related to friction between two pieces of metal in the machinery that puts stoppers on the vials, Moderna said in the joint statement with Takeda. The material was confirmed to be stainless steel.

Moderna conducted its investigation in partnership with Takeda and Spanish manufacturer Rovi, which operates the plant where the contamination occurred.

“Stainless steel is routinely used in heart valves, joint replacements and metal sutures and staples. As such, it is not expected that injection of the particles identified in these lots in Japan would result in increased medical risk,” Takeda and Moderna said in a joint statement.

Moderna shares were up 2.6% following the statement. Shares of Rovi were up than 4.5% after falling more than 10% on news of the dose suspensions. Takeda shares rose more than 2%.

Administration of the Moderna shots from the three lots was suspended in Japan after 39 vials were found to contain foreign material. All the vials came from a single lot, but shots from two other lots from the same Rovi manufacturing line were suspended as a precaution.

Those three lots were the only ones affected by the manufacturing issue, the statement said. Rovi has fully inspected its manufacturing facility and implemented new procedures to avoid similar problems in the future, it added.

Use of the Moderna vaccine from different batches also was temporarily halted in three regions in Japan this week. In some cases, foreign substances were found in unused vials, while others appear to have been the result of incorrectly inserted needles causing bits of the vials’ rubber stopper break off.

The contamination issue gained more attention after the health ministry said on Saturday that two men, aged 38 and 30, died in August within days of receiving their second Moderna doses. Each had received a dose from one of the suspended lots.

The cause of death in the two cases is still being investigated.

Moderna and Takeda said in the joint statement that there was no evidence the fatalities were caused by the vaccine. “The relationship is currently considered to be coincidental,” the companies said in the statement.

About 500,000 people have received shots from the three suspended Moderna batches, Taro Kono, Japan’s minister in charge of the vaccination campaign, told reporters on Friday. Moderna said it cannot confirm how many doses were distributed from the batches.

(Reporting by Rocky Swift in Tokyo and Carl O’Donnell in New York; Editing by Andrew Heavens, Paul Simao and Bill Berkrot)

 

www.gawdo.com
Share on FacebookShare on TwitterShare on Linkedin
0 FacebookTwitterPinterestEmail
previous post
One million without power as Ida leaves trail of destruction
next post
Oil dips; OPEC+ sticks to gradual output hikes

You may also like

UK first to approve Omicron COVID shot with...

August 15, 2022

Restart Scheme is ‘restarting’ careers across South West...

July 29, 2022

Zoho celebrates bumper year, after hitting 80 million...

July 28, 2022
Editorial & Advertiser disclosureEditorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gawdo.com
https://www.gawdo.com
  • About us
  • Advertising & Terms of Use
  • Contact Us
  • Privacy Policy

@2021 - All Right Reserved.


Back To Top
Startup Observer.com
  • Home
  • Industries
  • Innovation
  • outsourcing
  • Business
  • Finance
  • Headlines
  • Opinion
  • News
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT